Outcomes of Nivolumab Plus Ipilimumab After Atezolizumab Plus Bevacizumab in Advanced HCC: An International Multicentre Study
晚期肝细胞癌患者在接受阿特珠单抗联合贝伐珠单抗治疗后,再接受纳武利尤单抗联合伊匹木单抗治疗的疗效:一项国际多中心研究
期刊:Liver International
影响因子:5.2
doi:10.1111/liv.70493
Kim, Jung Sun; Wong, Jeffrey; Chen, San-Chi; Tai, David; Yang, Hannah; Kim, Youngun; Kang, Beodeul; Kim, Ilhwan; Kim, Hyeyeong; An, Chansik; Jang, Su Jin; Kudo, Masatoshi; Lim, Ho Yeong; Kim, Chan; Yau, Thomas; Chon, Hong Jae